UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

Annals of internal medicine, 1989-12, Vol.111 (12), p.992

1989

Volltextzugriff (PDF)

Erythropoietin for End-Stage Renal Disease

The New England journal of medicine, 1998-08, Vol.339 (9), p.625-627

1998

Volltextzugriff (PDF)

Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy

Kidney international, 1999-03, Vol.55 (S69), p.S35-S43

1999

Volltextzugriff (PDF)

The future of r-HuEPO

Nephrology, dialysis, transplantation, 1995, Vol.10, p.96-109

ESCHBACH, J. W

1995

Volltextzugriff (PDF)

Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications

American journal of kidney diseases, 2000-07, Vol.36 (1), p.1-11

2000

Volltextzugriff (PDF)

Anemia of end-stage renal disease (ESRD)

Kidney international, 1985-07, Vol.28 (1), p.1-5

1985

Volltextzugriff (PDF)

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients

Clinical nephrology, 1997-07, Vol.48 (1), p.1

1997

Volltextzugriff (PDF)

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects

Kidney international, 1992-08, Vol.42 (2), p.407-416

1992

Volltextzugriff (PDF)

Erythropoietin 1991 : an overview

American journal of kidney diseases, 1991-10, Vol.18 (4), p.3-9

ESCHBACH, J. W

1991

Volltextzugriff (PDF)

Erythropoietin: the promise and the facts

Kidney international. Supplement, 1994-01, Vol.44, p.S70

Eschbach, J W

1994

Volltextzugriff (PDF)

The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin

Kidney international, 1989-01, Vol.35 (1), p.134-148

Eschbach, Joseph W.

1989

Volltextzugriff (PDF)

Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative

American journal of kidney diseases, 2001-01, Vol.37 (1), p.179-194

2001

Volltextzugriff (PDF)

Intravenous versus subcutaneous dosing of Epoetin alfa in hemodialysis patients

American journal of kidney diseases, 1995-08, Vol.26 (2), p.331-340

1995

Volltextzugriff (PDF)

The anemia of end-stage renal disease: Hematopoietic progenitor cell response

Kidney international, 1988-05, Vol.33 (5), p.983-988

1988

Volltextzugriff (PDF)

Hypertension Following Erythropoietin Therapy in Anemic Hemodialysis Patients

American journal of hypertension, 1990-12, Vol.3 (12-Pt-1), p.947-955

1990

Volltextzugriff (PDF)

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?

Nephrology, dialysis, transplantation, 2002-01, Vol.17 (suppl-5), p.2-7

2002

Volltextzugriff (PDF)

The long-term effects of recombinant human erythropoietin on the cardiovascular system

Clinical nephrology, 1992, Vol.38 Suppl 1, p.S98

1992

Volltextzugriff (PDF)

Effects of erythropoietin on strength and functional status of patients on hemodialysis

Clinical nephrology, 1993-02, Vol.39 (2), p.97

1993

Volltextzugriff (PDF)

Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI

Seminars in nephrology, 2000-07, Vol.20 (4), p.320-329

Eschbach, J W

2000

Volltextzugriff (PDF)

Guidelines for recombinant human erythropoietin therapy

American journal of kidney diseases, 1989-08, Vol.14 (2 Suppl 1), p.2-8

1989

Volltextzugriff (PDF)

Treatment of the Anemia of Chronic Renal Failure with Recombinant Human Erythropoietin

Annual review of medicine, 1990-01, Vol.41 (1), p.349-360

1990

Volltextzugriff (PDF)

The anemia of chronic renal failure in sheep: response to erythropoietin-rich plasma in vivo

The Journal of clinical investigation, 1984-08, Vol.74 (2), p.434-441

1984

Volltextzugriff (PDF)

Recombinant human erythropoietin: implications for nephrology

American journal of kidney diseases, 1988-03, Vol.11 (3), p.203-209

1988

Volltextzugriff (PDF)

Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity

Kidney international, 1986-03, Vol.29 (3), p.641-648

1986

Volltextzugriff (PDF)

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

Contributions to nephrology, 1989, Vol.76, p.160

1989

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(140)
Japanisch
(17)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Humans
(81)
Life Sciences & Biomedicine
(77)
Anemia - Etiology
(34)
Urology & Nephrology
(34)
Kidney Failure, Chronic - Complications
(33)
Female
(32)
Renal Dialysis
(31)
Erythropoietin - Therapeutic Use
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Male
(25)
Adult
(24)
Anemia - Drug Therapy
(22)
Hematocrit
(19)
Recombinant Proteins - Therapeutic Use
(19)
Animals
(18)
Middle Aged
(18)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

Erythropoietin for End-Stage Renal Disease

Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy

The future of r-HuEPO

Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-dialysis outcomes quality initiative clinical practice guidelines: Description, findings, and implications

Anemia of end-stage renal disease (ESRD)

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects

Erythropoietin 1991 : an overview

Erythropoietin: the promise and the facts

The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin

Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative

Intravenous versus subcutaneous dosing of Epoetin alfa in hemodialysis patients

The anemia of end-stage renal disease: Hematopoietic progenitor cell response

Hypertension Following Erythropoietin Therapy in Anemic Hemodialysis Patients

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?

The long-term effects of recombinant human erythropoietin on the cardiovascular system

Effects of erythropoietin on strength and functional status of patients on hemodialysis

Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI

Guidelines for recombinant human erythropoietin therapy

Treatment of the Anemia of Chronic Renal Failure with Recombinant Human Erythropoietin

The anemia of chronic renal failure in sheep: response to erythropoietin-rich plasma in vivo

Recombinant human erythropoietin: implications for nephrology

Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients

Suchergebnisse filtern